BioAge Labs, Inc. Common Stock

BIOA XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

970M

Short interest (Jul 15)

5.5%

Net Short (Jul 27 ): 0.1%

Borrow Fee

0.41%

↑ 16.9%

Available Shares

300K

↑ 16.9%

Price Chart

Company Overview

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001709941

Asset Type: CS

Market Data

Market Cap: $967,736,019

Employees: 62

Status: Active

Short Interest

Current Borrow Fee 0.41%

Range: 0.41% - 0.43%

Available Shares 300K

Range: 300K - 350K

Recent Changes

Fee Change: ↓ 14.2%

Available Change: ↓ 18.8%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime